Ramot at Tel Aviv University Ltd.
http://www.ramot.org/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Ramot at Tel Aviv University Ltd.
Pacts In Medtech, July/August 2017
Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech column pulls up notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we highlight industry pacts that were sealed in July and August 2017.
Recent Tech Transfer Deals (10/2011)
Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.
BioLineRx licenses compound for neuropathic and inflammatory pain
Jerusalem-based BioLineRx has signed a worldwide, exclusive licence agreement with Ramot, the technology transfer arm of Tel Aviv University, in order to gain access to the early-stage compound BL-7050, an orally available molecule for neuropathic and inflammatory pain. Financial terms were not disclosed.
Cell-Based Solutions for Neurologic Disease
Emerging tissue-engineering and cell transplantation therapies have the potential to provide solutions to many of the treatment challenges facing neurologists today.
Company Information
- Industry
- Academic and Research Institutions
- Other Names / Subsidiaries
-
- Tel Aviv University
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice